Swiss Economy Braces for Impact: US Tariffs and the Road Ahead
The Swiss economy faces a significant challenge as new US tariffs, specifically a 39% levy on certain Swiss products, have come into effect. While last-minute diplomatic efforts proved unsuccessful, the focus now shifts to understanding the immediate impact and potential future strategies for Swiss businesses.
Who Feels the Pinch? The Industries Most at Risk
The Swiss watch and tech industries are particularly vulnerable. The US is the largest single market for Swiss watches, accounting for roughly one-fifth of all exports in 2024. The tech industry also faces significant challenges, with concerns that the tariffs could erode profit margins, making Swiss products less competitive compared to rivals from the EU and Japan.
Jean-Philippe Kohl from Swissmem, a leading industry association, noted that a 39% tariff could wipe out profit margins, effectively pricing Swiss companies out of the US market. This isn’t just about large corporations; many small and medium-sized enterprises (SMEs) rely on the US market for a significant portion of their revenue.
Did you know? The Swiss watch industry exported approximately $7.6 billion worth of timepieces to the United States in 2024.
The Exception to the Rule: A Temporary Reprieve
There is a limited exception. Goods loaded onto ships bound for the US before the tariffs took effect on August 7th, 2025, will be subject to the previous tariff rates until October 5th, 2025. Additionally, the chemical and pharmaceutical industries have been granted a grace period until the end of September, allowing them to propose measures to lower drug prices in the US.
This reprieve offers a temporary buffer, but the long-term implications remain a concern. Understanding international trade regulations is now more critical than ever for Swiss exporters.
The Agricultural Impact: Gruyère and Beyond
The agricultural sector isn’t immune. The US is the second-largest importer of Swiss cheese, particularly Gruyère. Emmi, a major Swiss dairy company, had already increased prices in the US in anticipation of the tariffs. Further adjustments are expected, raising concerns about how American consumers will react. Other processed foods with Swiss ingredients, such as milk chocolate and biscuits, are also affected.
Pro Tip: Swiss companies may need to explore alternative markets and diversify their export destinations to mitigate risks.
Navigating the Storm: Business Strategies in a Tariff Environment
Relocating production to the US solely to avoid tariffs is not a viable option for most Swiss companies, particularly SMEs. While larger companies with existing US facilities may shift some production steps to the EU for export to the US, this strategy comes at the cost of reduced value creation in Switzerland.
Many businesses expedited shipments before the deadline. However, this strategy only provides short-term relief. The focus must shift to longer-term solutions, potentially exploring alternative markets.
The Pharmaceutical Dilemma: A High-Stakes Waiting Game
The Swiss pharmaceutical industry faces unique pressures. US President Trump has requested proposals to lower drug prices in the US by the end of September, threatening tariffs as high as 250% if no agreement is reached. This situation poses significant risks to the industry, with potential consequences including higher costs, reduced investment, supply chain disruptions, and compromised patient care.
The stakes are incredibly high. Pharmaceuticals account for a significant portion of Swiss exports to the US, totaling over 64 billion francs. Swissmedic, the Swiss Agency for Therapeutic Products, plays a crucial role in ensuring the quality and safety of these exports.
Industry Demands: What Swiss Associations Want
Swiss business associations advocate for measures to alleviate the burden on exporters. Counter-tariffs are deemed ineffective due to the small size of the Swiss market. Instead, the focus is on domestic relief measures, such as extending the maximum duration for short-time work compensation to 24 months.
Economiesuisse emphasizes the importance of strong relationships with the EU, advocating for swift ratification of the Bilateral Agreements III. Swissmem calls for new free trade agreements, particularly with South America, and a more moderate climate policy to avoid disadvantaging Swiss exports. Find out more about the Swiss economy here.
FAQ: US Tariffs and the Swiss Economy
- What are the new US tariffs on Swiss goods?
- The US has imposed tariffs of up to 39% on certain Swiss products.
- Which industries are most affected?
- The Swiss watch, tech, and agricultural industries are most impacted.
- Is there any relief for Swiss exporters?
- Yes, goods already in transit to the US before August 7th, 2025, are subject to previous tariff rates until October 5th, 2025.
- What are Swiss business associations recommending?
- They advocate for domestic relief measures, free trade agreements, and a more moderate climate policy.
- What’s the status of the pharmaceutical industry?
- The pharmaceutical industry has a grace period until the end of September to propose measures to lower drug prices in the US.
What strategies do you think Swiss businesses should adopt to navigate these challenges? Share your thoughts in the comments below!